InspireMD (NSPR)
NASDAQ:NSPR
Want to see NSPR full AI Analyst Report?
Total Valuation
InspireMD has a market cap or net worth of $46.84M. The enterprise value is $37.52M.
Market Cap$46.84M
Enterprise Value$37.52M
Share Statistics
InspireMD has 46,838,963 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,838,963
Owned by Insiders21.25%
Owned by Institutions36.98%
Financial Efficiency
InspireMD’s return on equity (ROE) is -0.88 and return on invested capital (ROIC) is -83.68%.
Return on Equity (ROE)-0.88
Return on Assets (ROA)-0.70
Return on Invested Capital (ROIC)-83.68%
Return on Capital Employed (ROCE)-0.84
Revenue Per Employee105.64K
Profits Per Employee-573.95K
Employee Count85
Asset Turnover0.13
Inventory Turnover1.86
Valuation Ratios
The current PE Ratio of InspireMD is 103.6. InspireMD’s PEG ratio is 0.00.
PE Ratio103.6
PS Ratio14.56
PB Ratio2.37
Price to Fair Value2.37
Price to FCF-3.56
Price to Operating Cash Flow-1.90
PEG Ratio0.00
Income Statement
In the last 12 months, InspireMD had revenue of 8.98M and earned -48.79M in profits. Earnings per share was -0.76.
Revenue8.98M
Gross Profit2.65M
Operating Income-49.11M
Pretax Income-48.72M
Net Income-48.79M
EBITDA-48.64M
Earnings Per Share (EPS)-0.76
Cash Flow
In the last 12 months, operating cash flow was -38.65M and capital expenditures -1.50M, giving a free cash flow of -40.15M billion.
Operating Cash Flow-38.65M
Free Cash Flow-40.15M
Free Cash Flow per Share-0.86
Dividends & Yields
InspireMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.31
52-Week Price Change-60.47%
50-Day Moving Average1.36
200-Day Moving Average1.88
Relative Strength Index (RSI)30.35
Average Volume (3m)102.59K
Important Dates
InspireMD upcoming earnings date is Aug 11, 2026, Before Open (Confirmed).
Last Earnings DateMay 4, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
InspireMD as a current ratio of 5.74, with Debt / Equity ratio of 4.68%
Current Ratio5.74
Quick Ratio5.42
Debt to Market Cap0.00
Net Debt to EBITDA0.14
Interest Coverage Ratio0.00
Taxes
In the past 12 months, InspireMD has paid 63.00K in taxes.
Income Tax63.00K
Effective Tax Rate>-0.01
Enterprise Valuation
InspireMD EV to EBITDA ratio is -2.55, with an EV/FCF ratio of -3.37.
EV to Sales13.82
EV to EBITDA-2.55
EV to Free Cash Flow-3.37
EV to Operating Cash Flow-3.53
Balance Sheet
InspireMD has $41.57M in cash and marketable securities with $2.04M in debt, giving a net cash position of $39.53M billion.
Cash & Marketable Securities$41.57M
Total Debt$2.04M
Net Cash$39.53M
Net Cash Per Share$0.84
Tangible Book Value Per Share$0.75
Margins
Gross margin is 28.06%, with operating margin of -546.97%, and net profit margin of -543.33%.
Gross Margin28.06%
Operating Margin-546.97%
Pretax Margin-542.63%
Net Profit Margin-543.33%
EBITDA Margin-541.66%
EBIT Margin-546.97%
Analyst Forecast
The average price target for InspireMD is $3.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$3.67
Price Target Upside99.28% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast54.38%
EPS Growth Forecast7.25%